🕒 Monday 19 October 2026 Mon, 19 Oct 2026

Emerald Resources delivered a sharp lift in FY26 profit as its Okvau gold mine generated the cash to fund two new developments. The debt-free, unhedged producer is now moving Dingo Range and Memot from permitting and study work towards construction, while warning that key reserves and timing milestones are still ahead.

International Equities Corporation has returned to a modest annual profit after exiting serviced apartments, but the recovery is fragile. Cash fell sharply, operating cash flow remained negative and the auditor highlighted material uncertainty over the group’s ability to continue as a going concern.

Sunshine Metals is moving Mt Moss toward a planned mid-2027 first gold pour, but its annual report carries a material uncertainty over going concern as the company faces a $10 million deferred payment and roughly $30 million of development spending. The ASX-listed explorer reported a narrower FY2026 loss and $20.57 million in cash after a year of major capital raisings and project expansion.

S&P Global Ratings has lowered Bank of Queensland’s long-term issuer credit rating from A- to BBB+, adding a fresh market signal after the bank’s FY26 results. BOQ says the downgrade is not expected to materially affect its capital, liquidity or funding position, and has left its guidance unchanged.

Metro Mining has reset its 2026 bauxite shipment guidance to 6.0-6.5 million wet metric tonnes after September performance fell below plan. The company is relying on channel repairs, stronger staffing and a drier weather outlook to recover shipments before its February maintenance shutdown.

Finexia Financial Group subsidiary Shared Beginnings has entered voluntary administration after Finexia decided to stop providing further financial support. The move places seven early learning centres across three jurisdictions under administrator control, while the potential financial impact on Finexia remains uncertain.

M Battery Materials has lodged a prospectus for a $15 million to $25 million IPO, taking its proposed acquisition of LE Minerals’ Queensland graphite assets into a more concrete phase. The transaction still requires LE Minerals shareholder approval and successful ASX admission.

Tasmea delivered record FY26 earnings and lifted its FY27 guidance, as the WorkPac acquisition reshaped the group and the newly completed Maxim and JPS deals move into the numbers. The opportunity is substantial, but so is the execution task: margin mix, integration and earn-out obligations now matter more than ever.

CZR Resources has reported its strongest Top Camp gold intercept to date, including 0.70 metres at 67.2 grams per tonne, while rock chips point to high-grade iron targets near BHP’s Yarrie operations. The results strengthen the exploration case, but further drilling is needed to establish continuity, thickness and scale.

White Cliff Minerals shareholders have approved an A$8.77 million placement to Hancock Prospecting, giving the private company an expected 13.5% stake and funding a faster exploration campaign at Rae. The capital is aimed at advancing Danvers 1 towards a maiden resource while testing a much larger copper system across Nunavut.

Helix Resources has closed a $2 million placement to fund exploration across its Pilbara gold projects, but the issue still needs shareholder approval at an extraordinary meeting on 21 October. The deal adds 50 million shares and 50 million attaching options to the company’s capital structure.

ActivEX has increased the Mt Hogan project’s Inferred Mineral Resource by 30% to 403,000 ounces of contained gold, even after accounting for historical mining. The gain is encouraging, but the estimate remains global and Inferred, with coarse-gold sampling and data-quality gaps still limiting confidence.

Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.

Love Group’s customer cash receipts fell to A$626,000 in the first quarter of FY27, with management blaming a sharp drop in Google Ads return on spend. The company ended September with A$2.014 million in cash and an estimated eight quarters of funding at the latest burn rate.

Echelon Resources has spudded the second and final well in its Palm Valley appraisal campaign, targeting the south flank of the Northern Territory gas field. The company expects the two wells to restore facility capacity to about 14 TJ a day and support at least 10 PJ of gas production, although both drilling and tie-in work remain incomplete.

Critical Minerals Group is seeking up to $2.05 million to begin definitive feasibility work at its Lindfield Vanadium Project, backed by existing shareholders and a new non-executive director. The raise could increase shares on issue by 27% if fully subscribed, with key related-party commitments still requiring approval.

K&S Corporation’s FY2026 annual report confirms a sharp earnings decline, a lower dividend and rising debt as weak demand, margin pressure and the loss of most InfraBuild work weigh on the logistics group. Management expects FY2027 to remain difficult, with no formal earnings guidance provided.

Actinogen Medical says its pivotal XanaMIA Alzheimer’s trial remains on course for topline results in November after the final patient visit was completed. The company also reported $15.9 million in cash, a further $5.3 million from option funding and a projected runway into late 2027 or 2028, assuming future trials are substantially partner-funded.

TG Metals has advanced its Van Uden gold development and Lake Johnston lithium project, including a high-return heap-leach study and a maiden 6.71Mt lithium resource. But the ASX explorer ended September with A$1.523 million in cash, equivalent to just 1.05 quarters of funding at the reported spending rate.

Firebird Metals has produced 99.999% ultra-high-purity manganese sulphate at its Hunan pilot plant and started processing ore from its Western Australian Oakover project. The next test is whether the result can be independently replicated with Australian feedstock before the Perth demonstration plant begins commissioning in 2027.

Provaris Energy’s share purchase plan attracted preliminary applications of $755,000, exceeding its $600,000 target. The company will accept the oversubscription, with the final amount, issue price and share allocation due on 21 October.

Cobalt Blue has signed a non-binding term sheet with Swiss trader STG Metals for cobalt metal from its proposed Kwinana refinery. The proposed deal covers up to 1,000 tonnes a year, but construction, product qualification and a definitive agreement remain outstanding.

Kingsrose Mining has promoted CEO Andy Caruso to managing director and added him to the board, while proposing a substantial incentive package subject to shareholder approval. The appointment formalises his leadership as the company pursues acquisitions and Scandinavian exploration.

Acrux has received clearer FDA guidance for Phase III trials of its female testosterone spray, including potential three-year data exclusivity if the product reaches submission. The company also reported positive September-quarter operating cash flow, but that result was largely driven by a $1.977 million R&D tax rebate and Acrux says it is still pursuing funding for the clinical programme.